Retinoprotective therapy of glaucoma
<p> A.S. Makarova </p> <p> Krasnov Research Institute of Eye Diseases, Moscow, Russian Federation </p> <p> <b>Background</b>: a fluctuating blood pressure (BP) and particularly an overnight hypotension is the key adverse factor leading to the progressio...
Saved in:
Main Author: | A.S. Makarova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Prime-Media
2022-11-01
|
Series: | РМЖ "Клиническая офтальмология" |
Online Access: | http://clinopht.com/upload/iblock/c2b/axlf98p8a5xy184p0s3juog11nhnspod.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Place of retinoprotective therapy in modern ophthalmologic practice
by: E.A. Egorov, et al.
Published: (2018-07-01) -
Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
by: Jan M. Keppel Hesselink, et al.
Published: (2015-01-01) -
Characteristics of glaucoma therapy with prostaglandin analogues nowadays
by: I.B. Alekseev, et al.
Published: (2022-09-01) -
Systemic therapy a risk factor for glaucoma development and progression
by: A.M. Getmanova, et al.
Published: (2020-11-01) -
Neovascular glaucoma as a complication of proton therapy for uveal melanoma
by: I.E. Panova, et al.
Published: (2024-12-01)